These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 25921386)

  • 21. Selective elimination of leukemia stem cells: hitting a moving target.
    Crews LA; Jamieson CH
    Cancer Lett; 2013 Sep; 338(1):15-22. PubMed ID: 22906415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting LSCs through membrane antigens selectively or preferentially expressed on these cells.
    Pelosi E; Castelli G; Testa U
    Blood Cells Mol Dis; 2015 Dec; 55(4):336-46. PubMed ID: 26460257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
    Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Role of Hypoxic Bone Marrow Microenvironment in Acute Myeloid Leukemia and Future Therapeutic Opportunities.
    Bruno S; Mancini M; De Santis S; Monaldi C; Cavo M; Soverini S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemia stem cells and microenvironment: biology and therapeutic targeting.
    Konopleva MY; Jordan CT
    J Clin Oncol; 2011 Feb; 29(5):591-9. PubMed ID: 21220598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the leukemia microenvironment.
    Konopleva M; Andreeff M
    Curr Drug Targets; 2007 Jun; 8(6):685-701. PubMed ID: 17584025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting bone marrow lymphoid niches in acute lymphoblastic leukemia.
    Uy GL; Hsu YM; Schmidt AP; Stock W; Fletcher TR; Trinkaus KM; Westervelt P; DiPersio JF; Link DC
    Leuk Res; 2015 Dec; 39(12):1437-42. PubMed ID: 26467815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
    Kogan AA; Lapidus RG; Baer MR; Rassool FV
    Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Niche displacement of human leukemic stem cells uniquely allows their competitive replacement with healthy HSPCs.
    Boyd AL; Campbell CJ; Hopkins CI; Fiebig-Comyn A; Russell J; Ulemek J; Foley R; Leber B; Xenocostas A; Collins TJ; Bhatia M
    J Exp Med; 2014 Sep; 211(10):1925-35. PubMed ID: 25180064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age-related differences in the bone marrow stem cell niche generate specialized microenvironments for the distinct regulation of normal hematopoietic and leukemia stem cells.
    Lee GY; Jeong SY; Lee HR; Oh IH
    Sci Rep; 2019 Jan; 9(1):1007. PubMed ID: 30700727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding of the crosstalk between normal residual hematopoietic stem cells and the leukemic niche in acute myeloid leukemia.
    Batsivari A; Grey W; Bonnet D
    Exp Hematol; 2021 Mar; 95():23-30. PubMed ID: 33497761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?
    Tavor S; Petit I
    Semin Cancer Biol; 2010 Jun; 20(3):178-85. PubMed ID: 20637871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia.
    Bolandi SM; Pakjoo M; Beigi P; Kiani M; Allahgholipour A; Goudarzi N; Khorashad JS; Eiring AM
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming the Niche: The Emerging Role of Extracellular Vesicles in Acute Myeloid Leukaemia Progression.
    Mendes M; Monteiro AC; Neto E; Barrias CC; Sobrinho-Simões MA; Duarte D; Caires HR
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.
    Ye H; Adane B; Khan N; Sullivan T; Minhajuddin M; Gasparetto M; Stevens B; Pei S; Balys M; Ashton JM; Klemm DJ; Woolthuis CM; Stranahan AW; Park CY; Jordan CT
    Cell Stem Cell; 2016 Jul; 19(1):23-37. PubMed ID: 27374788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview: Cancer Stem Cell and Tumor Environment.
    Minami Y
    Oncology; 2015; 89 Suppl 1():22-4. PubMed ID: 26551001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches.
    Menter T; Tzankov A
    Front Immunol; 2022; 13():811144. PubMed ID: 35273598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGFBP7 Induces Differentiation and Loss of Survival of Human Acute Myeloid Leukemia Stem Cells without Affecting Normal Hematopoiesis.
    Verhagen HJMP; van Gils N; Martiañez T; van Rhenen A; Rutten A; Denkers F; de Leeuw DC; Smit MA; Tsui ML; de Vos Klootwijk LLE; Menezes RX; Çil M; Roemer MGM; Vermue E; Heukelom S; Zweegman S; Janssen JJWM; Ossenkoppele GJ; Schuurhuis GJ; Smit L
    Cell Rep; 2018 Dec; 25(11):3021-3035.e5. PubMed ID: 30540936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.